Lionsgate Studios (NYSE: LION) director reports equity grants in Form 4

Rhea-AI Filing Summary

Lionsgate Studios Corp. director Richard Rosenblatt reported new equity compensation in the form of common shares and restricted share units. On November 28, 2025, he acquired 20,107 restricted share units as his annual director equity award at a price of $0, which will vest into an equal number of common shares on November 28, 2026. He also received 5,421 common shares at a price of $7.46 as payment of director fees in stock. Following these transactions, he beneficially owns 55,545 common shares of Lionsgate Studios Corp. directly.

Insider Trade Summary

Net Buyer: 25,528 shares

Net Buy 2 txns

Insider Rosenblatt M Richard

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	20,107	$0.00	$0.00
Grant/Award	Common Shares	5,421	$7.46	$40K

Holdings After Transaction: Common Shares — 55,545 shares (Direct)

Footnotes (3)

1. F1. Annual director equity award.
2. F2. Amount includes 20,107 restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer, that are scheduled to vest on November 28, 2026.
3. F3. Director fees paid in common shares.

FAQ

What insider transaction did Lionsgate Studios (LION) report in this Form 4?

The Form 4 reports that director Richard Rosenblatt acquired 20,107 restricted share units as an annual director equity award and 5,421 common shares as director fees paid in stock on November 28, 2025.

How many Lionsgate Studios (LION) shares does the reporting director own after the transaction?

After the reported transactions, director Richard Rosenblatt beneficially owns 55,545 common shares of Lionsgate Studios Corp., held directly.

What are the terms of the restricted share units granted by Lionsgate Studios (LION)?

The director received 20,107 restricted share units that are scheduled to vest on November 28, 2026. Upon vesting, each unit is payable in one common share of Lionsgate Studios Corp..

Why did Lionsgate Studios (LION) issue additional common shares to the director?

The filing states that 5,421 common shares were issued as director fees paid in common shares, effectively compensating the director with stock instead of cash fees.

What was the reported price for the Lionsgate Studios (LION) share grants?

The 20,107 restricted share units were granted at a reported price of $0 as an equity award, while the 5,421 common shares issued as director fees had a reported price of $7.46 per share.

What role does the reporting person hold at Lionsgate Studios (LION)?

The reporting person, Richard Rosenblatt, is identified as a director of Lionsgate Studios Corp. and filed the Form 4 as a single reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/02/2025 - 04:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rosenblatt M Richard

(Last) (First) (Middle)

LIONSGATE STUDIOS CORP.

2700 COLORADO AVE.

(Street)

SANTA MONICA CA 90404

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lionsgate Studios Corp. [ LION ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	11/28/2025		A		20,107(1)	A	$0	50,124(2)	D
Common Shares	11/28/2025		A		5,421(3)	A	$7.46	55,545(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual director equity award.

2. Amount includes 20,107 restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer, that are scheduled to vest on November 28, 2026.

3. Director fees paid in common shares.

Remarks:

	Richard Rosenblatt (By Adrian Kuzycz by Power of Attorney)	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.